BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 19 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | +20.0% | 8,049 | +71.5% | 0.00% | – |
| Q2 2022 | $5,000 | -70.6% | 4,692 | -54.4% | 0.00% | – |
| Q1 2022 | $17,000 | +6.2% | 10,294 | +43.8% | 0.00% | – |
| Q4 2021 | $16,000 | +166.7% | 7,161 | +169.7% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 2,655 | +61.4% | 0.00% | – |
| Q2 2021 | $5,000 | – | 1,645 | +164400.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q2 2020 | $43,000 | +760.0% | 1,860 | +96.8% | 0.00% | – |
| Q1 2019 | $5,000 | -64.3% | 945 | -68.4% | 0.00% | – |
| Q4 2018 | $14,000 | -44.0% | 2,992 | -34.3% | 0.00% | – |
| Q3 2018 | $25,000 | +212.5% | 4,552 | +259.8% | 0.00% | – |
| Q2 2018 | $8,000 | -27.3% | 1,265 | -38.7% | 0.00% | – |
| Q1 2018 | $11,000 | – | 2,065 | +1606.6% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 121 | -91.3% | 0.00% | – |
| Q2 2016 | $5,000 | -61.5% | 1,393 | -60.2% | 0.00% | – |
| Q3 2015 | $13,000 | 0.0% | 3,502 | +35.3% | 0.00% | – |
| Q2 2015 | $13,000 | – | 2,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRUE Private Wealth Advisors | 55,500 | $64,000 | 0.01% |
| Aspire Private Capital, LLC | 1,600 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,540 | $3,000 | 0.00% |
| UBS Group AG | 4,692 | $5,000 | 0.00% |
| CREDIT AGRICOLE S A | 4,240 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $16,000 | 0.00% |
| MORGAN STANLEY | 33,281 | $39,000 | 0.00% |
| Renaissance Technologies | 18,300 | $21,000 | 0.00% |